Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

Publication | Open Access

DOI Full Paper Access

300

Citations

References

2022

Year

Ana Oaknin, Lucy Gilbert, Anna V. Tinker, Jubilee Brown, Cara Mathews, Joshua Z. Press, Renaud Sabatier, David M. O’Malley, Vanessa Samouëlian, Valentina Boni,

Journal for ImmunoTherapy of Cancer

Abstract

References